Holen Sie sich die Stockscreener-App
125.98
1.77%
2.19
Vorhandelsmarkt:
127.69
1.71
+1.36%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$123.79
Offen:
$123.11
24-Stunden-Volumen:
1.03M
Relative Volume:
0.51
Marktkapitalisierung:
$19.26B
Einnahmen:
$4.34B
Nettoeinkommen (Verlust:
$850.00M
KGV:
23.06
EPS:
5.4635
Netto-Cashflow:
$921.00M
1W Leistung:
+4.25%
1M Leistung:
+2.51%
6M Leistung:
+33.44%
1J Leistung:
+43.13%
1-Tages-Spanne:
$122.27
$126.67
1-Wochen-Bereich:
$119.61
$128.19
52-Wochen-Spanne:
$68.70
$155.53
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
125.98 | 19.26B | 4.34B | 850.00M | 921.00M | 5.4635 |
TMO
Thermo Fisher Scientific Inc
|
490.29 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.10 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
570.21 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.20 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
301.92 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. stock faces ongoing challenges from Grail divestiture and genomics market pressures - AD HOC NEWS
Illumina Inc. stock faces headwinds amid Grail divestiture scrutiny and biotech sector slowdown - AD HOC NEWS
Illumina price gives in to negative pressureForecast today24-03-2026 - Economies.com
US Multiomic Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Illumina : CSR Report (2025 illumina france gender pay gap english) - marketscreener.com
Illumina : CSR Report (2025 illumina gender pay gap uk) - marketscreener.com
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop - The Motley Fool
Prediction Tool Market Poised for Rapid Growth as AI and Genomics - openPR.com
Canaccord reiterates Hold on Illumina stock amid Roche competition - Investing.com
Nordea Investment Management AB Boosts Stake in Illumina - National Today
Nordea Investment Management AB Has $124.15 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina TruPath™ Genome supports a more comprehensive genome analysis - Illumina
Illumina Inc. stock faces renewed scrutiny amid Grail divestiture delays and biotech sector headwind - AD HOC NEWS
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - MSN
Swiss Life Asset Management Ltd Purchases 67,772 Shares of Illumina, Inc. $ILMN - MarketBeat
Here’s Why Illumina Could Continue Its 47% Last Year Rally - TIKR.com
Illumina, Inc. (NASDAQ:ILMN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina and Labcorp Expand Precision Oncology Testing Partnership - Oncodaily
Illumina, Inc. $ILMN Shares Sold by CIBC Private Wealth Group LLC - MarketBeat
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Says China Removed Ban on Importing DNA Sequencers - MSN
ILMN Stock Gains Following Expanded Collaboration With Labcorp - TradingView
In Canada, researching the use of AI to accelerate answers for rare disease - Illumina
DNA Sequencing Market size to hit $108.95 Billion by 2035 | Top - openPR.com
JPMorgan Chase Boosts Illumina Stake by 17.5% - National Today
JPMorgan Chase & Co. Acquires 124,246 Shares of Illumina, Inc. $ILMN - MarketBeat
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina and Labcorp expand cancer testing collaboration - Investing.com India
Illumina, Labcorp Expand Collaboration to Advance Precision Oncology Testing - marketscreener.com
Synthetic Biology Market to Reach US$ 67.47 Billion by 2033 | - openPR.com
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - Yahoo Finance
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing - PR Newswire
Investment Report: Is Illumina Inc stock a good dividend stockPortfolio Update Report & Weekly Breakout Watchlists - baoquankhu1.vn
U.S. Bioinformatics Market Is Booming Rapidly with Strong - openPR.com
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Gotham Asset Management LLC Purchases 144,475 Shares of Illumina, Inc. $ILMN - MarketBeat
How Illumina’s Genomics Insurance Push And Multiomic Alliance Expansion At Illumina (ILMN) Has Changed Its Investment Story - simplywall.st
Illumina Adds Activist to Board, Names Former FDA Chief as Chair - MSN
Illumina partners with Veritas Genetics to advance preventive genomics - National Today
Illumina Stock: Here’s Why Numbers Suggest a 63% Upside - TIKR.com
Illumina partners with Veritas to offer genome sequencing via insurers - Investing.com
Illumina advances preventive genomics through strategic consortium with Veritas Genetics - PR Newswire
Illumina, Inc. $ILMN Shares Sold by Ion Asset Management Ltd. - MarketBeat
Bamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN - National Today
Illumina, Inc. $ILMN Stake Lessened by Cannell & Spears LLC - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Casdin Capital LLC - MarketBeat
Illumina Inc. Stock (ISIN: US4523271090) Gains on Institutional Buying and Genomic Alliance Momentum - AD HOC NEWS
Illumina (ILMN) Valuation Check As Genomic Discovery Alliance Expansion Draws Fresh Investor Interest - simplywall.st
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Is It Time To Reconsider Illumina (ILMN) After Prolonged Share Price Weakness? - Yahoo Finance
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
2.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):